loader

World Tenders & Procurement Opportunities

Conclusion of non-exclusive discount agreements according to § 130a Para. 8 SGB V for the in II.2.4. mentioned active ingredients with the possibility of conclusion within the framework of the so-called open-house procedure.

World Biggest Tenders Source

This tender with title Conclusion of non-exclusive discount agreements according to § 130a Para. 8 SGB V for the in II.2.4. mentioned active ingredients with the possibility of conclusion within the framework of the so-called open-house procedure. --

Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4. genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
has been published on Bidding Source portal dated 17 Jul 2023 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4. genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.

General Information

Conclusion of non-exclusive discount agreements according to § 130a Para. 8 SGB V for the in II.2.4. mentioned active ingredients with the possibility of conclusion within the framework of the so-called open-house procedure.
Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4. genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Invitation for Bids
2023/S 132-419788
Germany
Germany-Hanover
17 Jul 2023
30 Jun 2024
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Pharmaceutical products – 52nd Generika tender_FL - 276729-2024 Germany Conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the possibility of conclusion as part of the so-called open house procedure. - 281075-2024 Germany Open house contracts for several active ingredients/combinations of active ingredients - 280844-2024 Germany Conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V (open house model) - 280564-2024 Germany Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for medicines with the active ingredient lacosamide (ATC code: N03AX18). - 270710-2024 Germany Open framework agreement on drug discounts in accordance with Section 130a Paragraph 8 SGB V with the possibility of joining at any time, so-called approval model 2023-07 - 272983-2024 Germany Pharmaceutical products – VV_76_patent - 270240-2024 Germany Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for medicines with the active ingredient promethazine (ATC code: N05CM22). - 269960-2024 Germany Open framework agreement on drug discounts in accordance with Section 130a Paragraph 8 SGB V with the possibility of joining at any time, so-called approval model 2024-05 - 269524-2024 Germany Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for medicines with the active ingredient lenograstim (ATC code: L03AA10). - 270038-2024 Germany
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans